Benefits of opportunistic screening for sexually transmitted infections in primary care

An epidemic of the bacterial sexually transmitted infections (STIs) syphilis, chlamydia and gonorrhea is taking hold worldwide, with the World Health Organization estimating that nearly 1 million people are infected daily with a curable STI. Canada has seen increases of more than 160% over the last...

Full description

Saved in:
Bibliographic Details
Published in:Canadian Medical Association journal (CMAJ) 2021-04, Vol.193 (16), p.E566-E567
Main Authors: Grennan, Troy, MD MSc, Tan, Darrell H.S., MD PhD
Format: Article
Language:English
Subjects:
Asymptomatic
Chlamydia
Clinical trials
Diagnosis
Global health
Gonorrhea
Health care
HIV
Human immunodeficiency virus
Infections
Infectious diseases
Inflammatory diseases
Internal Medicine
Patients
Pelvic inflammatory disease
Practice guidelines (Medicine)
Preventive medicine
Primary care
Primary health care
Public health
Sexual health
Sexual orientation
Sexually transmitted diseases
Stigma
Systematic review
Task forces
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An epidemic of the bacterial sexually transmitted infections (STIs) syphilis, chlamydia and gonorrhea is taking hold worldwide, with the World Health Organization estimating that nearly 1 million people are infected daily with a curable STI. Canada has seen increases of more than 160% over the last decade. A critical component of STI control is testing, but a paucity of evidence on how best to do this, particularly with respect to screening frequency, means recommendations on the topic are scarce. Here, Grennan and Tan discuss the benefits of screening for STIs in primary care.
ISSN:0820-3946
1488-2329
DOI:10.1503/cmaj.210604